Sort by
Refine Your Search
-
Employer
- ICN2
- Universitat de Barcelona
- Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré (IRBLleida)
- Institute for bioengineering of Catalonia, IBEC
- Autonomous University of Madrid (Universidad Autónoma de Madrid)
- BIOGIPUZKOA HEALTH RESEARCH INSTITUTE
- Institut d'Investigació Biomèdica Sant Pau
- Institute of Photonic Sciences
- Universitat Rovira i Virgili
- Basque Center for Macromolecular Design and Engineering, POLYMAT Fundazioa
- Centre for Genomic Regulation
- Computer Vision Center
- Forest Science and Technology Centre of Catalonia
- Fundacion IMDEA Energia
- Fundació Centre de Recerca en Agrotecnologia-AGROTECNIO
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Fundació per a la Universitat Oberta de Catalunya
- Fundación IMDEA Materiales
- ICMAB
- ISGLOBAL
- Institut Barcelona d'Estudis Internacionals
- Institute of Chemical Research of Catalonia ICIQ
- Instituto de Neurociencia Avanzada de Barcelona
- Josep Carreras Leukaemia Research Institute (IJC)
- Maimonides Biomedical Research Institute of Cordoba - IMIBIC
- The Chinese Institutes for Medical Research (CIMR), Beijing
- UNIOVI
- UNIVERSIDAD POLITECNICA DE MADRID
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- Universitat de les Illes Balears
- 21 more »
- « less
-
Field
-
, reports and proposals, and establish interdisciplinary collaborations. The position will also involve supervision of undergraduate students and the development of research projects with strong translational
-
function of these cells, we combine directed differentiation of human pluripotent stem cells, in vitro and in vivo models of human normal and leukemic development, and state-of-the-art epigenomic and
-
to developing an HR Strategy for Researchers, designed to bring the practices and procedures in line with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment
-
resistance. We developed synthetic cells that fight bacteria using a biomimetic form of artificial phagocytosis, a process to date only observed in living organisms. These phagocytic synthetic cells (PSCs
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
evaluation and development of novel PEC systems. · Design and implement in-situ TEM experiments using the available gas and liquid sample holders to study dynamic processes in real-time, under controlled